- Migraine Canada - https://migrainecanada.org -

A case demonstrating how a combination of Botox and erenumab can improve person’s quality of life: research from a Quebec team

Both Botox and CGRP antibodies can be effective for Chronic Migraine [1]. Still, 50 to 50% of patients do not get this response for Botox or CGRP antibodies. What if a combination was used? 

A team from Quebec City reports on a 52 years-old woman suffering from chronic migraine [1]. This woman had tried other preventives (amitriptyline [2], propranolol, duloxetine, candesartan, verapamil) and she was using a lot of acute meds (rizatriptan, fiorinal ¼, Gravol, Demerol, Tylenol and medical cannabis). 

Over a year and a half, she was treated with either Botox alone, Aimovig alone or a combination, with four phases. In the end, the conclusion was that the combination was required for her to be optimally controlled. 

 Before treatmentBotox phase
Nov 2017
Botox + Aimovig Dec 2018- Feb 2019Aimovig only March-May 2019Botox + Aimovig July-Sept 2019 
 Number per month on a mean over the observation period Similar improvements were seen for Gravol, Fiorinal and cannabinoid use
Migraine [3] Days271810151
ER visits3-41020
Triptan dose9,86,34,791,5
Tylenol dose67423311030
Demerol dose107,55,8143,6

The authors detail many arguments to support the combination of Botox and a monoclonal antibody. A post from Migraine Canada can be found here [4].

This case is only one case.

It is not a research on hundreds of people with elaborate statistics. It is not an ultimate proof. But this person’s story illustrates a few important things about people with chronic migraine [3]

Read the full article here [5]

Research makes a difference. We need more research on migraine and headaches in Canada! 

Stay tuned, as Migraine Canada may post calls for testimonials and stories about migraine treatments.